NCT00316459View on ClinicalTrials.gov

Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2006

Conditions
HealthyLong QT Syndrome
Interventions
DRUG

ERB-041

Trial Locations (1)

33126

Miami

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00316459 - Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects | Biotech Hunter | Biotech Hunter